Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
NanoTomer Logo
NanoTomer CB Rank
750032
Heat Score
59
NanoTomer innovative and cutting edge technologies, our primary objective is to improve patient outcomes.
Founded
obfuscation
Private Boston, Massachusetts, United States www.nanotomer.com/
Biotechnology
Health Care
Overview

NanoTomer
Heat Score
59

Growth Score
pts
in past quarter
Heat Score 59
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About NanoTomer

CB Rank
750032
NanoTomer innovative and cutting edge technologies, our primary objective is to improve patient outcomes.
Founded
obfuscation
Private Boston, Massachusetts, United States www.nanotomer.com/
Biotechnology
Health Care

Key People

Details

Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

MHA112 Antibody Drug Conjugate
An antibody designed to target cancer cells, linked to drug conjugates for direct delivery of pharmaceuticals to tumors and metastases.
Protin101 Peptide Drug Conjugate
A peptide used as a platform for drug conjugates aimed at targeted delivery of pharmaceuticals or activation of T-cells in cancer and autoimmune therapies.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Employee Profiles 1 Contacts 1

Employee Profiles

News
Technology
View Tech Report

IT Spend

$372.6KThis year, NanoTomer is projected to spend $372.6K on IT, according to Aberdeen.

Active Website Tech Count

2NanoTomer is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 100m.

Total IP

1NanoTomer has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is NanoTomer's headquarters? NanoTomer is located in Boston, Massachusetts, United States.Who are NanoTomer's competitors? Alternatives and possible competitors to NanoTomer may include AbbVie, Tubulis, and  CytomX Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3e39328 1)
|